• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用视紫红质的组成性激活突变体制备激活的视紫红质/转导蛋白复合物。

Preparation of an activated rhodopsin/transducin complex using a constitutively active mutant of rhodopsin.

机构信息

Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02454, United States.

出版信息

Biochemistry. 2011 Nov 29;50(47):10399-407. doi: 10.1021/bi201126r. Epub 2011 Nov 2.

DOI:10.1021/bi201126r
PMID:21995315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3390202/
Abstract

The interaction of rhodopsin and transducin has been the focus of study for more than 30 years, but only recently have efforts to purify an activated complex in detergent solution materialized. These efforts have used native rhodopsin isolated from bovine retina and employed either sucrose density gradient centrifugation or size exclusion chromatography to purify the complex. While there is general agreement on most properties of the activated complex, subunit stoichiometry is not yet settled, with rhodopsin/transducin molar ratios of both 2/1 and 1/1 reported. In this report, we introduce methods for preparation of the complex that include use of recombinant rhodopsin, so as to take advantage of mutations that confer constitutive activity and enhanced thermal stability on the protein, and immunoaffinity chromatography for purification of the complex. We show that chromatography on ConA-Sepharose can substitute for the immunoaffinity column and that bicelles can be used instead of detergent solution. We demonstrate the following: that rhodopsin has a covalently bound all-trans-retinal chromophore and therefore corresponds to the active metarhodopin II state; that transducin has an empty nucleotide-binding pocket; that the isolated complex is active and dissociates upon addition of guanine nucleotide; and finally that the stoichiometry corresponds reproducibly to a 1/1 molar ratio of rhodopsin to transducin.

摘要

视紫红质与转导蛋白的相互作用已经成为研究焦点 30 多年,但直到最近,人们才努力在去污剂溶液中纯化激活复合物。这些努力使用从牛视网膜中分离的天然视紫红质,并采用蔗糖密度梯度离心或大小排阻色谱法来纯化复合物。尽管人们对激活复合物的大多数性质都达成了共识,但亚基比例尚未确定,报告的视紫红质/转导蛋白摩尔比既有 2/1 也有 1/1。在本报告中,我们介绍了制备复合物的方法,包括使用重组视紫红质,以利用赋予蛋白质组成活性和增强热稳定性的突变,以及免疫亲和色谱法纯化复合物。我们表明,ConA-琼脂糖上的色谱可以替代免疫亲和柱,并且双分子层可以替代去污剂溶液。我们证明了以下几点:视紫红质具有共价结合的全反式视黄醛发色团,因此对应于活性视紫红质 II 状态;转导蛋白具有空的核苷酸结合口袋;分离的复合物是活性的,并在添加鸟嘌呤核苷酸时解离;最后,摩尔比可重复性地对应于视紫红质与转导蛋白的 1/1 摩尔比。

相似文献

1
Preparation of an activated rhodopsin/transducin complex using a constitutively active mutant of rhodopsin.使用视紫红质的组成性激活突变体制备激活的视紫红质/转导蛋白复合物。
Biochemistry. 2011 Nov 29;50(47):10399-407. doi: 10.1021/bi201126r. Epub 2011 Nov 2.
2
Crystallization scale preparation of a stable GPCR signaling complex between constitutively active rhodopsin and G-protein.组成型活性视紫红质与G蛋白之间稳定的GPCR信号复合物的结晶规模制备。
PLoS One. 2014 Jun 30;9(6):e98714. doi: 10.1371/journal.pone.0098714. eCollection 2014.
3
Assembly of an activated rhodopsin-transducin complex in nanoscale lipid bilayers.在纳米尺度脂质双层中组装激活的视紫红质转导蛋白复合物。
Biochemistry. 2014 Jan 14;53(1):127-34. doi: 10.1021/bi4012995. Epub 2013 Dec 20.
4
Isolation and structure-function characterization of a signaling-active rhodopsin-G protein complex.一种具有信号活性的视紫红质 - G蛋白复合物的分离及结构 - 功能表征
J Biol Chem. 2017 Aug 25;292(34):14280-14289. doi: 10.1074/jbc.M117.797100. Epub 2017 Jun 27.
5
Isolation and functional characterization of a stable complex between photoactivated rhodopsin and the G protein, transducin.光激活视紫红质与G蛋白转导素之间稳定复合物的分离及功能特性研究
FASEB J. 2009 Feb;23(2):371-81. doi: 10.1096/fj.07-114835. Epub 2008 Sep 30.
6
Phospholipids are needed for the proper formation, stability, and function of the photoactivated rhodopsin-transducin complex.磷脂对于光激活视紫红质 - 转导蛋白复合物的正常形成、稳定性及功能是必需的。
Biochemistry. 2009 Jun 16;48(23):5159-70. doi: 10.1021/bi900284x.
7
Rhodopsin controls a conformational switch on the transducin gamma subunit.视紫红质控制转导蛋白γ亚基上的构象转换。
Structure. 2003 Apr;11(4):367-73. doi: 10.1016/s0969-2126(03)00045-5.
8
A switch 3 point mutation in the alpha subunit of transducin yields a unique dominant-negative inhibitor.转导素α亚基中的一个开关3点突变产生一种独特的显性负性抑制剂。
J Biol Chem. 2005 Oct 21;280(42):35696-703. doi: 10.1074/jbc.M504935200. Epub 2005 Aug 15.
9
Rhodopsin/transducin interactions. I. Characterization of the binding of the transducin-beta gamma subunit complex to rhodopsin using fluorescence spectroscopy.
J Biol Chem. 1992 Aug 25;267(24):17032-9.
10
Chemical modification of transducin with iodoacetic acid: transducin-alpha carboxymethylated at Cys(347) allows transducin binding to Light-activated rhodopsin but prevents its release in the presence of GTP.用碘乙酸对转导素进行化学修饰:在半胱氨酸(347)处羧甲基化的转导素-α允许转导素与光激活的视紫红质结合,但在存在鸟苷三磷酸(GTP)的情况下阻止其释放。
Arch Biochem Biophys. 2001 Nov 15;395(2):146-57. doi: 10.1006/abbi.2001.2550.

引用本文的文献

1
Disrupted Plasma Membrane Protein Homeostasis in a Model of Retinitis Pigmentosa.视网膜色素变性模型中的血浆膜蛋白稳态失调。
J Neurosci. 2019 Jul 10;39(28):5581-5593. doi: 10.1523/JNEUROSCI.3025-18.2019. Epub 2019 May 6.
2
The route of the visual receptor rhodopsin along the cilium.视杆细胞视紫红质沿着纤毛的途径。
J Cell Sci. 2019 May 15;132(10):jcs229526. doi: 10.1242/jcs.229526.
3
Ligand channel in pharmacologically stabilized rhodopsin.药理学稳定视紫红质中的配体通道。
Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):3640-3645. doi: 10.1073/pnas.1718084115. Epub 2018 Mar 19.
4
Purification and Characterization of RhoPDE, a Retinylidene/Phosphodiesterase Fusion Protein and Potential Optogenetic Tool from the Choanoflagellate Salpingoeca rosetta.罗氏领鞭毛虫视黄叉/磷酸二酯酶融合蛋白RhoPDE的纯化与特性分析及其作为潜在光遗传学工具的研究
Biochemistry. 2017 Oct 31;56(43):5812-5822. doi: 10.1021/acs.biochem.7b00519. Epub 2017 Oct 18.
5
Isolation and structure-function characterization of a signaling-active rhodopsin-G protein complex.一种具有信号活性的视紫红质 - G蛋白复合物的分离及结构 - 功能表征
J Biol Chem. 2017 Aug 25;292(34):14280-14289. doi: 10.1074/jbc.M117.797100. Epub 2017 Jun 27.
6
Expression, purification, and spectral tuning of RhoGC, a retinylidene/guanylyl cyclase fusion protein and optogenetics tool from the aquatic fungus .来自水生真菌的视黄叉/鸟苷酸环化酶融合蛋白及光遗传学工具RhoGC的表达、纯化及光谱调谐
J Biol Chem. 2017 Jun 23;292(25):10379-10389. doi: 10.1074/jbc.M117.789636. Epub 2017 May 4.
7
Decay of an active GPCR: Conformational dynamics govern agonist rebinding and persistence of an active, yet empty, receptor state.活性G蛋白偶联受体的衰变:构象动力学决定激动剂的重新结合以及活性但空的受体状态的持续时间。
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11961-11966. doi: 10.1073/pnas.1606347113. Epub 2016 Oct 4.
8
Relocating the Active-Site Lysine in Rhodopsin: 2. Evolutionary Intermediates.视紫红质中活性位点赖氨酸的重新定位:2. 进化中间体。
Biochemistry. 2016 Aug 30;55(34):4864-70. doi: 10.1021/acs.biochem.6b00478. Epub 2016 Aug 12.
9
Stabilization of G protein-coupled receptors by point mutations.通过点突变实现G蛋白偶联受体的稳定化
Front Pharmacol. 2015 Apr 20;6:82. doi: 10.3389/fphar.2015.00082. eCollection 2015.
10
Crystallization scale preparation of a stable GPCR signaling complex between constitutively active rhodopsin and G-protein.组成型活性视紫红质与G蛋白之间稳定的GPCR信号复合物的结晶规模制备。
PLoS One. 2014 Jun 30;9(6):e98714. doi: 10.1371/journal.pone.0098714. eCollection 2014.

本文引用的文献

1
Crystal structure of the β2 adrenergic receptor-Gs protein complex.β2 肾上腺素能受体-Gs 蛋白复合物的晶体结构。
Nature. 2011 Jul 19;477(7366):549-55. doi: 10.1038/nature10361.
2
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.激动剂结合的腺苷 A2A 受体结构揭示了 G 蛋白偶联受体激活的共同特征。
Nature. 2011 May 18;474(7352):521-5. doi: 10.1038/nature10136.
3
Structure of an agonist-bound human A2A adenosine receptor.激动剂结合的人 A2A 腺苷受体结构。
Science. 2011 Apr 15;332(6027):322-7. doi: 10.1126/science.1202793. Epub 2011 Mar 10.
4
Crystal structure of metarhodopsin II.视紫红质 II 的晶体结构。
Nature. 2011 Mar 31;471(7340):651-5. doi: 10.1038/nature09789. Epub 2011 Mar 9.
5
The structural basis of agonist-induced activation in constitutively active rhodopsin.激动剂诱导的固有激活状态视紫红质激活的结构基础。
Nature. 2011 Mar 31;471(7340):656-60. doi: 10.1038/nature09795. Epub 2011 Mar 9.
6
Coupling efficiency of rhodopsin and transducin in bicelles.双脂体中视紫红质与转导蛋白的偶联效率。
Biochemistry. 2011 Apr 19;50(15):3193-203. doi: 10.1021/bi200037j. Epub 2011 Mar 25.
7
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.激动剂和部分激动剂在β(1)-肾上腺素能受体上作用的结构基础。
Nature. 2011 Jan 13;469(7329):241-4. doi: 10.1038/nature09746.
8
Structure and function of an irreversible agonist-β(2) adrenoceptor complex.不可逆激动剂-β(2)肾上腺素能受体复合物的结构与功能。
Nature. 2011 Jan 13;469(7329):236-40. doi: 10.1038/nature09665.
9
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.β2 肾上腺素能受体的纳米体稳定的活性状态结构。
Nature. 2011 Jan 13;469(7329):175-80. doi: 10.1038/nature09648.
10
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.人源多巴胺 D3 受体与 D2/D3 选择性拮抗剂复合物的结构。
Science. 2010 Nov 19;330(6007):1091-5. doi: 10.1126/science.1197410.